Legal and professional costs overhang
Elevated legal costs of INR 6-7 crore in Q2 due to ongoing litigation; timing of resolution is uncertain and could continue to pressure margins.
FORTIS / Q2-FY24 / risks
Keep the risk register visible.
Fortis Healthcare · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
medium
Doctor cost inflation and talent churn
Analyst raised concern about rising guaranteed payouts for clinicians; management acknowledged some churn but deemed risk low. However, cost pressures could impact margin trajectory.
Delays in bed commissioning
Management identified potential delays in brownfield bed commissioning as a key risk to achieving FY25 margin targets.
Low-margin oncology mix drags margins
Rapid growth in medical oncology (lower margin) relative to surgical oncology could cap margin expansion despite absolute EBITDA growth.